Echo Therapeutics (ECTE) Reports In-Line Q2 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Loss from operations: -1.81M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Loss from operations: -1.81M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q2 loss of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $121.46 thousand versus the consensus estimate of $100 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
